Jules H.Cantor

Associate

Chicago + 1.312.269.1503

Jules Cantor focuses his practice on complex litigation, with an emphasis on securities and shareholder litigation, as well as corporate and government investigation matters.

Jules has substantial experience with securities fraud class actions, shareholder derivative lawsuits, books-and-records and other shareholder demands, investigations conducted by the Securities and Exchange Commission (SEC) and the Department of Justice (DOJ), and Financial Industry Regulatory Authority (FINRA) arbitrations. He coordinates the Firm's publication efforts for its SEC Enforcement in Financial Reporting and Disclosure series and contributes to its Securities Litigation Year in Review.

Jules maintains an active pro bono practice, representing clients in immigration and civil rights litigation. Through the Firm's Border Project, Jules has first-chaired a trial team that secured a grant of asylum and has successfully defended several clients' relief before the Board of Immigration Appeals. He also served as lead counsel at a bond hearing that resulted in a client's release from custody after a federal court granted the client's petition for a writ of habeas corpus. Additionally, Jules participates actively in the Firm's Hate Crimes Task Force.

Jules served as co-chair of the Anti-Defamation League's (ADL) Glass Leadership Institute Chicago cohort for 2022 and served as co-chair of ADL's Midwest Associate Board in 2023. He will serve again as ADL's Midwest Associate Board co-chair in 2024.

Experience

  • CD&R and its two director-designees defend against claims in post-closing shareholder merger litigationJones Day represents Clayton, Dubilier & Rice, LLC and two of its designees to the board of directors of Covetrus, Inc. in a post-closing shareholder challenge to the approximately $4 billion acquisition of Covetrus by funds affiliated with CD&R and another third party.
  • Multinational Fortune 500 company resolves SEC accounting issues investigation and obtains declination from DOJJones Day represented a multinational Fortune 500 company in a SEC and DOJ investigation regarding accounting issues related to multiple company projects in the U.S. and several countries around the world.
  • Securities broker-dealer defends unsuitability claims in FINRA arbitration mattersJones Day is defending a large securities broker-dealer in several FINRA arbitrations related to claims of unsuitable investment recommendations.
  • GrafTech directors win dismissal of claims challenging share buyback transaction with its controlling stockholderJones Day successfully defended directors of GrafTech International, Ltd. in shareholder derivative litigation challenging GrafTech's $250 million buyback of stock from its then-controlling stockholder.
  • Experian secures affirmance of dismissals of FCRA claims surrounding legal question of debt ownershipJones Day successfully represented Experian Information Solutions, Inc. ("Experian") in consolidated appeals before the United States Court of Appeals for the Seventh Circuit, seeking affirmance of the United States District Court for the Northern District of Illinois' dismissals of several plaintiffs' claims under the Fair Credit Reporting Act ("FCRA").
  • Biotechnology company defends against expedited statutory claim by director seeking inspection of corporate books and recordsJones Day represented a clinical-stage biotechnology company in expedited statutory proceedings.
  • Flowers Foods resolves putative securities class actionsJones Day represented Flowers Foods, Inc. in two putative securities fraud class actions filed against Flowers and certain officers and directors.
  • The Southern Company defends putative securities class action alleging violations of Section 10(b)Jones Day is representing The Southern Company and its directors and certain of its current and former officers in connection with a putative class action alleging, among other things, violations of Section 10(b) of the Securities Exchange Act of 1934.